Immediate Impact
43 standout
Citing Papers
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
2024 Standout
New epilepsy therapies in development
2024 Standout
Works of Robert Wapenaar being referenced
Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) receiving real-life current standard of care (SOC) in the LocoMMotion study.
2022
A pooled analysis of adjunctive topiramate in refractory partial epilepsy
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robert Wapenaar | 85 | 70 | 81 | 115 | 25 | 285 | |
| Ming‐Sun Yu | 26 | 45 | 49 | 53 | 30 | 320 | |
| Maria Rosana Ponisio | 118 | 35 | 65 | 64 | 25 | 302 | |
| Tammy Z. Movsas | 15 | 66 | 28 | 46 | 26 | 335 | |
| Sara Bongiovanni | 21 | 16 | 80 | 27 | 21 | 309 | |
| F. Imbesi | 138 | 39 | 35 | 14 | 18 | 274 | |
| Alessandra Franzoni | 28 | 42 | 13 | 51 | 32 | 287 | |
| John D. Scarlett | 29 | 27 | 43 | 73 | 19 | 254 | |
| Jennifer Poon | 67 | 111 | 15 | 39 | 16 | 275 | |
| Christian Jehn | 16 | 55 | 39 | 43 | 15 | 306 | |
| Xuerui Tan | 19 | 24 | 35 | 42 | 17 | 324 |
All Works
Loading papers...